Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 40 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 10722550

    Compositions and methods for the treatment of fungal infections

    Arizona Board of Regents on Behalf of Northern Arizona University · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  2. US 10723803

    CD47 targeted therapies for the treatment of infectious disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 28, 2020 · Expires Jul 23, 2040

    granted

  3. US 10716782

    LPT-723 and immune checkpoint inhibitor combinations and methods of treatment

    Biomed Valley Discoveries, Inc. · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  4. US 10717748

    1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases

    Takeda Pharmaceutical Company Limited · Granted Jul 21, 2020 · Expires Jul 16, 2040

    granted

  5. US 10711029

    Beta-d-2′-deoxy-2′-alpha-fluoro-2′-beta-c-substituted-4′fluoro-n6-substituted-6-amino-2-substituted purine nucleotides for the treatment of hepatitis c virus infection

    Atea Pharmaceuticals, Inc. · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  6. US 10711312

    Methods for immunotherapy-based treatment and assessment of cancer

    The Regents of the University of California · Granted Jul 14, 2020 · Expires Jul 9, 2040

    granted

  7. US 10703797

    Gene therapy vectors for treatment of Danon disease

    Rocket Pharmaceuticals, Ltd. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  8. US 10703735

    4-phenyl-coumarin derivatives, processes for their preparation and uses thereof for the treatment of cancer

    Lead Discovery Center GmbH · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  9. US 10703701

    Fluoroalkyl, fluoroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders

    PTC THERAPEUTICS, INC. · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  10. US 10702569

    Compositions and methods for treatment of pain

    Princeton Biotechnology Corporation · Granted Jul 7, 2020 · Expires Jul 2, 2040

    granted

  11. US 10695355

    Methods for pharmacologic treatment of stroke

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  12. US 10696718

    Compstatin analogs for treatment of neuropathic pain

    Apellis Pharmaceuticals, Inc. · Granted Jun 30, 2020 · Expires Jun 25, 2040

    granted

  13. US 10688080

    Compositions, methods of use, and methods of treatment

    The Regents of the University of California · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  14. US 10689443

    Humanized monoclonal antibodies and methods of use for the diagnosis and treatment of colon and pancreas cancer

    PRECISION BIOLOGICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  15. US 10688181

    Cancer treatment combinations

    The Regents of the University of California · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  16. US 10688102

    Combination treatment for migraine and other pain

    AXSOME THERAPEUTICS, INC. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  17. US 10689646

    Treatment of genetic disorders associated with DNA repeat instability

    BIOMARIN TECHNOLOGIES B.V. · Granted Jun 23, 2020 · Expires Jun 18, 2040

    granted

  18. US 10682339

    Pharmaceutical compositions directly targeting FKBP52 for the treatment of prostate cancer and methods of using same

    The Board of Regents of the University of Texas System · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  19. US 10683503

    Antisense oligomers for treatment of conditions and diseases

    STOKE THERAPEUTICS, INC. · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  20. US 10683366

    Methods and compositions for treatment of atherosclerosis

    The Board of Regents of the University of Texas System · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  21. US 10683347

    Treatment of cancer using anti-TGF-β and anti-PD-1 antibodies

    The Regents of the University of California · Granted Jun 16, 2020 · Expires Jun 11, 2040

    granted

  22. US 10677801

    Diagnosis and treatment of breast cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  23. US 10675271

    Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy

    Monopar Therapeutics Inc. · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

  24. US 10676533

    Methods of treatment of CD123 overexpressing disorders

    Aptevo Research and Development LLC · Granted Jun 9, 2020 · Expires Jun 4, 2040

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.